EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Low-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings

Leslie M Swanson, Trevor de Sibour, Kelley DuBuc, Deirdre A Conroy, Greta B Raglan, Kate Lorang, Jennifer Zollars, Shelley Hershner, J Todd Arnedt, Helen J Burgess

Journal of Clinical Sleep Medicine · 2024

DOI: 10.5664/jcsm.11076 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Sleep Medicine, 2024. Verfasst von Leslie M Swanson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Melatonin, Actigraphy, Sleep Disorders, Circadian Rhythm. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY OBJECTIVES: The purpose of the present study was to preliminarily evaluate whether knowing the dim light melatonin onset (DLMO) time is advantageous when treating delayed sleep-wake phase disorder with low-dose melatonin treatment plus behavioral interventions (ie, evening dim light and time in bed scheduling). METHODS: In this randomized, controlled, double-blind trial, 40 adults with delayed sleep-wake phase disorder were randomly assigned to 4 weeks of 0.5 mg timed to be administered either 3 hours before the DLMO (measured DLMO group, n = 20) or 5 hours before sleep-onset time per actigraphy (estimated DLMO group, n = 20), in conjunction with behavioral interventions. The primary outcome was change in the DLMO (measured in-home). Secondary outcomes included sleep parameters per diary and actigraphy (sleep-onset and -offset times and total sleep time), Morningness-Eveningness Questionnaire, Multidimensional Fatigue Inventory, PROMIS-Sleep Disturbance, PROMIS-Sleep Related Impairment, and Pittsburgh Sleep Quality Index. Mixed-effects models tested for group differences in these outcome. RESULTS: After applying the Bonferroni correction for multiple comparisons (significant P value set at .004). CONCLUSIONS: Scheduled low-dose melatonin plus behavioral interventions may improve many circadian and sleep parameters regardless of whether melatonin administration is scheduled based on estimated or measured DLMO. A larger-scale trial is needed to confirm these preliminary findings. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Name: The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder; URL: https://clinicaltrials.gov/study/NCT03715465; Identifier: NCT03715465. CITATION: Swanson LM, de Sibour T, DuBuc K, et al. Low-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings. J Clin Sleep Med. 2024;20(7):1131-1140.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninActigraphySleep Disorders, Circadian RhythmHumansMaleFemaleDouble-Blind MethodMiddle AgedAdultCircadian RhythmTreatment OutcomeSurveys and QuestionnairesTime Factors

Stichwörter der Autor:innen

circadian rhythmsdelayed sleep-wake phase disorderdim light melatonin onsetmelatonin

Substanzen

Melatonin

Autor:innen und Institutionen

  • Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
  • Medical School, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Michigan Institute for Clinical & Health Research, University of Michigan, Ann Arbor, Michigan.
  • Department of Neurology, University of Michigan, Ann Arbor, Michigan.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Swanson, L. M., de Sibour, T., DuBuc, K., Conroy, D. A., Raglan, G. B., Lorang, K., Zollars, J., Hershner, S., Arnedt, J. T., & Burgess, H. J. (2024). Low-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.11076

Vancouver

Swanson LM, de Sibour T, DuBuc K, Conroy DA, Raglan GB, Lorang K, et al. Low-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings. Journal of Clinical Sleep Medicine. 2024. doi:10.5664/jcsm.11076

BibTeX
@article{Swanson2024,
  author = {Swanson, Leslie M and de Sibour, Trevor and DuBuc, Kelley and Conroy, Deirdre A and Raglan, Greta B and Lorang, Kate and Zollars, Jennifer and Hershner, Shelley and Arnedt, J Todd and Burgess, Helen J},
  title = {Low-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings},
  journal = {Journal of Clinical Sleep Medicine},
  year = {2024},
  doi = {10.5664/jcsm.11076}
}
Kostenlos starten →